Welcome to our dedicated page for MOUNTAIN VY MD news (Ticker: MVMDF), a resource for investors and traders seeking the latest updates and insights on MOUNTAIN VY MD stock.
Mountain Valley MD Inc (MVMDF) is a biotech company focused on utilizing its patented Quicksome™ technology to improve drug delivery and bioavailability. The company's core business involves developing innovative solutions for improving the effectiveness of pharmaceuticals, vaccines, and nutraceuticals. With a strong emphasis on research and development, Mountain Valley MD Inc has been making strides in the medical field by enhancing the absorption rates of various compounds. Their partnerships with leading healthcare organizations have enabled them to expand their reach and enhance their product portfolio. The company's commitment to innovation and scientific excellence has positioned them as a key player in the biotech industry.
Mountain Valley MD Holdings (MVMD) provided a year-end update on its commercialization progress across three core areas: Nutraceuticals, Agriculture, and Husbandry Animals/Aquatic Species. In Nutraceuticals, the company advanced its Quicksome™ technology through partnerships and product developments, including an OUD formulation and testosterone products. The agriculture division expanded its Agrarius technology presence, securing registrations in multiple countries and implementing a Performance Guarantee Program. In the Husbandry/Aquatic segment, their Soluvec™ 1% product achieved initial sales of 100 tonnes of coated fish feed in Bangladesh, with manufacturing resuming in November 2024 after cyclone-related disruptions.
Mountain Valley MD Holdings Inc. (MVMD) provided a business update on its three core lines: Nutraceuticals, Agriculture, and Husbandry Animals/Aquatic Species. Key developments include:
1. Nutraceuticals: Completed setup for Quicksome™ technology production. Launched Eons Deeper Sleep product with Circadian Wellness. Internal testing showed improved sleep metrics.
2. Agriculture: Acquired exclusive license for Agrarius agricultural technology in the Americas and Caribbean. Obtained product registration in EU, 44 US states, Canada, and Brazil. Launched Performance Guarantee Program for North American farmers.
3. Husbandry/Aquatic: Developed Soluvec™ 1% (solubilized Ivermectin) for animal applications. Licensed to a partner in Bangladesh for fish feed coating, with shipments planned for Q3 2024.